Article
Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - 1 Nov 2013
Hoem Dag, Straume Oddbjørn, Immervoll Heike, Akslen Lars A, Molven Anders
Abstract excerpt
In pancreatic ductal adenocarcinoma (PDAC), the benefit of current chemotherapy and radiation therapy is very limited, even in radically resected patients. New treatment strategies, for example based on the inhibition of the tumour's blood supply, need to be explored. We have investigated angiogenesis markers and their associations with relapse and survival in 52 histologically confirmed cases of PDAC....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
